| Name | 2-(4-chloropyridin-2-yl)-1,3,4-oxadiazole |
|---|---|
| Synonyms |
4-chloro-2-[1,3,4]oxadizol-2-yl-pyridine
4-chloro-2-(1,3,4-oxadiazol-2-yl)pyridine 4-chloro-2-[1,3,4]oxadizo-2-yl-pyridine |
| Density | 1.406g/cm3 |
|---|---|
| Boiling Point | 321.877ºC at 760 mmHg |
| Molecular Formula | C7H4ClN3O |
| Molecular Weight | 181.57900 |
| Flash Point | 148.466ºC |
| Exact Mass | 181.00400 |
| PSA | 51.81000 |
| LogP | 1.78500 |
| Index of Refraction | 1.569 |
| HS Code | 2934999090 |
|---|
|
~%
758709-88-5 |
| Literature: KALYPSYS, INC. Patent: US2007/155746 A1, 2007 ; Location in patent: Page/Page column 13; 16 ; US 20070155746 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |